Dr. Cordia T. Wan

Gabriel Zada, MD, MS, FAANS, FACS, is Professor of Neurological Surgery, Otolaryngology, and Physiology & Neuroscience at the Keck School of Medicine of USC and an internationally recognized leader in brain, skull base, and pituitary tumor surgery. He serves as Vice Chair of Education and Residency Program Director, Surgical Director of the USC Brain Tumor Center, and Director of the USC Endoscopic Skull Base Surgery Program.Dr. Zada has performed more than 3,000 cranial operations, specializing in minimally invasive and endoscopic approaches for brain, pituitary, and skull base tumors. He completed fellowship training under Dr. Edward Laws at Harvard/Brigham and Women’s Hospital and advanced training under Dr. Paolo Cappabianca in Naples, Italy.An NIH-funded investigator, Dr. Zada has authored more than 400 peer-reviewed publications and 3 surgical textbooks. He is Editor of *Neurosurgical Focus* and President-Elect of the AANS/CNS Joint Section on Tumors. FindExpertMD ranks him the **#1 neurosurgeon in California for pituitary tumors, meningiomas, skull base neoplasms, and neuroendoscopy**. He has treated patients from around the world including Mexico, Guam, Hawaii, Europe. South America, and Canada. Dr. Zada is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Hypothalamic Tumor, Brain Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Gamma Knife Radiosurgery. Dr. Zada is board certified in American Board Of Neurological Surgery.

Marvin Bergsneider is a Neurosurgery provider practicing medicine in Los Angeles, California. Dr. Bergsneider is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Hypothalamic Tumor, Brain Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Balloon Sinuplasty.

Dr. Tahseen Mozaffar is a Professor of Neurology, Orthopaedic Surgery and Pathology and Laboratory Medicine at University of California, Irvine. He is the Director of the UC Irvine-MDA ALS and Neuromuscular Center and the Director of the Division of Neuromuscular Diseases. Dr. Mozaffar serves as chair of one of the biomedical committees and the institutional liaison for Trials Innovation Hub for the Center for Translational Sciences Award (CTSA) at University of California, Irvine. He is the Principal Investigator for UCI-NEXT, the NeuroNEXT award to the University of California, Irvine, one of 25 such NeuroNEXT sites funded by the NINDS/NIH.. Dr. Mozaffar is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Pompe Disease, Inclusion Body Myositis, Myositis, Limb-Girdle Muscular Dystrophy, and Thymectomy. Dr. Mozaffar is board certified in Board Certification In Neurology, 1996-2026, Board Certification In Neuromuscular Medicine, 2008-2028, and Board Certification In Clinical Neuromuscular Pathology, 2015 - 2025. Dr. Mozaffar is currently accepting new patients.